views
The inherentadvantages of peptide therapeutics, such as small size, low immunogenicity andbetter cellular uptake, has led to a rise in interest in such interventions.This is anticipated to create significant opportunities for CMOs offeringpeptide manufacturing services. However, in order to meet the current andfuture demand, contract manufacturers may need to strengthen their respectivecapabilities and expand available capacities.
To order this 250+ pagereport, which features 100+ figures and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
The USD 3.2 billion (by 2030) financial opportunitywithin the peptide therapeutics contract API manufacturing market has beenanalyzed across the following segments:
§ Scale of Operation
§ Clinical
§ Commercial
§ Type of PeptideSynthesis Method Used
§ Chemical
§ Non-Chemical
§ Typeof Peptide Chemical Synthesis Method Used
- Liquid Phase Peptide Synthesis
- Solid Phase Peptide Synthesis
- Hybrid Phase Peptide Synthesis
§ Company Size
§ Small
§ Mid-sized
§ Large / Very Large
§ Key geographicalregions
§ North America
§ Europe
- Asia Pacific
The Peptide Therapeutics: Contract API Manufacturing Market,2020-2030”
report features thefollowing companies, which we identified to be key players in this domain:
§ AmbioPharm
§ Auspep
§ Bachem
§ BCN Peptide
§ Chinese Peptide
§ CordenPharma
§ CPC Scientific
§ Creative Peptides
§ CSBio
§ Hybio Pharmaceutical
§ PEPTIDE INSTITUTE
§ PolyPeptide Group
§ Senn Chemicals
§ Sinopharm Group
Table of Contents
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. REGULATORY LANDSCAPE
5. COMPETITIVE LANDSCAPE
6. COMPANY PROFILES
7. RECENT DEVELOPMENTS
8. CLINICAL TRIAL ANALYSIS
9. REGIONAL CAPABILITY ANALYSIS
10. DEMAND ANALYSIS
11. CAPACITY ANALYSIS
12. MAKE VERSUS BUY DECISION MAKING FRAMEWORK
13. MARKET SIZING AND OPPORTUNITY ANALYSIS
14. IMPACT OF THECOVID-19 PANDEMIC ON THE PEPTIDE API CONTRACT MANUFACTURING MARKET
15. SWOT ANALYSIS
16. CONCLUSION
17. SURVEY TRANSCRIPT(S)
18. APPENDIX 1: TABULATED DATA
19.APPENDIX 2: LIST OF COMPANIES ANDORGANISTIONS
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/peptide-therapeutics-manufacturing/305.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com